| Title |
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2014
|
| DOI | 10.1002/14651858.cd007784.pub2 |
| Pubmed ID | |
| Authors |
Suetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, David W Johnson, Vlado Perkovic, Jorgen Hegbrant, Giovanni FM Strippoli |
X Demographics
The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 10% |
| United States | 3 | 10% |
| Chile | 2 | 7% |
| Mexico | 1 | 3% |
| France | 1 | 3% |
| Canada | 1 | 3% |
| Argentina | 1 | 3% |
| Australia | 1 | 3% |
| Curaçao | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 16 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 73% |
| Practitioners (doctors, other healthcare professionals) | 4 | 13% |
| Scientists | 3 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 273 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| Ireland | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| China | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 264 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 55 | 20% |
| Student > Bachelor | 42 | 15% |
| Researcher | 26 | 10% |
| Other | 19 | 7% |
| Student > Ph. D. Student | 19 | 7% |
| Other | 44 | 16% |
| Unknown | 68 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 124 | 45% |
| Nursing and Health Professions | 25 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 4% |
| Agricultural and Biological Sciences | 7 | 3% |
| Psychology | 7 | 3% |
| Other | 19 | 7% |
| Unknown | 81 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2022.
All research outputs
#1,575,612
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,361
of 11,842 outputs
Outputs of similar age
#15,245
of 241,106 outputs
Outputs of similar age from Cochrane database of systematic reviews
#65
of 222 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,106 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.